Skip to main content
Clinical Trials/NCT02143349
NCT02143349UnknownPhase 3

Investigation of Appetite Suppressant Properties Associated With Coleus Forskohlii in Overweight and Obese Individuals

Olive Lifesciences Pvt Ltd2 sites in 1 country50 target enrollmentStarted: April 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Sponsor
Enrollment
50
Locations
2
Primary Endpoint
changes in appetite will be assessed using visual analogue scale; blood hormone levels will also be measured using commercial kits.

Study Overview

Brief Summary

Coleus forskohlii extract contains the bioactive compound, forskolin. Preliminary studies have shown that forskolin can increase fat metabolism thus reduce fat accumulation in both animals and humans. It has been suggested that forskolin may also suppress appetite thus reduce energy intake and results in weight loss. This study will evaluate the appetite suppressant properties of Coleus forskohlii extract. In addition the effect on central obesity and risk factors of metabolic syndrome will also be investigated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Both Australian males and females, age 20-60 years, Overweight or obese (BMI >25), waist circumference of > 94 cm (male), waist circumference of >80 cm (female)

Exclusion Criteria

  • Cigarette smoker, hypertension, all types of heart, liver and kidney disease, pregnancy, lactating, Type 1 diabetes and weight loss medication.

Outcomes

Primary Outcomes

changes in appetite will be assessed using visual analogue scale; blood hormone levels will also be measured using commercial kits.

Time Frame: Baseline and 12 weeks

Secondary Outcomes

  • reduction in central obesity - waist circumference will be measured on fortnight basis(12 weeks)

Investigators

Sponsor
Olive Lifesciences Pvt Ltd
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials